Antiretroviral therapy during pregnancy and the risk of an adverse outcome. - Wikidata - wikimedia - TriplyDB

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

http://www.wikidata.org/entity/Q33959672

about

Prevention of vertical transmission of HIV-1 in resource-limited settings Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study.Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions.HIV/AIDS epidemiology, pathogenesis, prevention, and treatment Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry.Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy.The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data.Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception Changes in Fertility at the Population Level in the Era of ART in Rural Malawi.Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study.Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs)Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.Mitochondrial toxicity in human pregnancy: an update on clinical and experimental approaches in the last 10 years.Antiretroviral regimens in pregnancy and breast-feeding in Botswana.Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women.Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana Safety and tolerability of antiretrovirals during pregnancy.Perinatal HIV transmission: developing country considerations.Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.Mother-to-child transmission of human immunodeficiency virus in aten years period Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women.Antiretroviral Therapy Use During Pregnancy and the Risk of Small for Gestational Age Birth in a Medicaid Population.HIV and pregnancy in Australia.Antiretroviral treatment of maternal HIV infection Trends in birth weight and gestational age for infants born to HIV-infected, antiretroviral treatment-naive women in Malawi Antiretroviral therapy and mother-to-child transmission of HIV-1.Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa.Maternal post-absorptive leucine kinetics during late pregnancy in US women with HIV taking antiretroviral therapy: a cross-sectional pilot study.German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008

P2860

Q22241479-6D7CB7F0-EBBC-402E-BEC4-13D6C17B4CA9 Q24236763-E749E88A-2963-41E9-94FB-A14C960C3CFF Q28066290-E684DFC3-8BE7-40F3-9E7E-28B2ED4CA895 Q30222338-85FA6B81-499E-4BD6-B6CA-84BAC34F778C Q30227236-867017EF-DDCC-4B54-820A-99DA60A2AAF9 Q30356074-24969E13-6305-488D-AE51-9EDB6CA13915 Q30987069-A5E1E7C8-5C42-4229-97B3-E0F2CC856787 Q33294899-043EE2B6-25A5-4CE6-B8AB-4D2CA906FA3E Q33441799-B8AFF983-9BC6-4CDF-BBB8-32E6AD9E6D0E Q33559823-352DDC18-8896-4F1F-8820-0019FBB54AA9 Q33667399-3CCF85A3-04DC-4F23-BDA2-04277307360C Q33747993-92482F7E-1474-4FFD-A7A5-7A1B55092425 Q33811136-7C925402-7F9C-4247-9450-2AC135075376 Q33830084-D1894A42-CEE5-4C50-AD67-1BA9CCCE1FBF Q33832976-46B8C9E6-6E1A-4244-96D1-8CE00809B556 Q34146634-136F5F1F-9315-4AC9-ADB7-DDCEB4A0B341 Q34158407-F0F1D6F8-C1D8-4812-B099-D4ADC2E5D130 Q34181776-56AE2B20-95FA-4955-B701-E299B91B49D3 Q34200645-057D1078-20C0-45DD-B17C-D008903C56E4 Q34306176-7840BE67-4C33-4CC1-9031-3851E264B766 Q34310482-0730A605-326C-4216-95E4-349BD5F75A30 Q34348392-DB058276-B61E-4119-89B6-0316762D2627 Q34395082-E2B04211-E773-4244-80B4-36AC46992EBC Q34399972-06AB8E08-88AC-42A8-8CB2-3C9DB0B51501 Q34500824-12BEFE13-1F28-4291-9207-B22D0C1E0CED Q34981966-342EFEC7-868A-4AFA-B80A-9D15685A856D Q35046412-CD07F693-6BE9-4500-B45B-9D3BFD561EF5 Q35184921-9522DC4F-E966-43ED-91F6-DC91317EF6B2 Q35551457-E9513104-0DC0-40FC-9786-9A51CC5E5AA5 Q35557216-9C22C7E7-66E8-4AF9-AFAE-BEDBDF3641A3 Q35639429-65ECE3AB-19DF-4959-82FB-9416B2AA723E Q35738557-FB010C77-9825-4A2C-AAE3-DC4E55C633E1 Q35738687-B062FAE3-AA2B-4E28-B720-BB14A64E73D3 Q35801717-D727C30A-57B6-4197-84AE-ACE81527B7FE Q35826189-70B46EEF-F803-4640-9780-5F4F8684B964 Q35897529-AFA22D5B-0467-497C-B861-01B772425C69 Q35917533-576B96A8-B618-4865-A361-954AA3419997 Q35921113-671235AB-E095-42F2-A100-688D66033A0F Q35927192-CBDE9827-1681-46AC-A64F-0C3058544170 Q35960319-EEF0B94B-F467-411B-8809-6BF23873CEC1

P2860

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

http://www.wikidata.org/entity/Q33959672

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

@ast

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

@en

type

label

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

@ast

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

@en

prefLabel

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

@ast

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

@en

P1433

Q33959672-0ABBE205-DDE1-4137-8D6F-C2EB625D0AA2

P1476

Q33959672-952C9799-5F41-4B52-90F8-9784902DF6FA

P2093

Q33959672-016012AE-0153-4993-9808-84E6FAA615D2

Q33959672-170FFE05-A316-4AC4-8919-07C50037BAFE

Q33959672-50B45467-7FA8-45A1-93B8-FFD0C9B0DC32

Q33959672-88F24CE0-3470-4B08-ACFD-6A42F2DD048F

Q33959672-9B2FACCB-A32F-4536-88B0-521F77E1AFF5

Q33959672-A438DF4E-DFDF-4CB5-AD0C-464B2E7C36E7

Q33959672-A6834812-09C6-4FB6-BEBF-221A59385BA5

Q33959672-B3507836-4DF6-478E-B435-DE4A589C29B5

Q33959672-F60AC093-22E6-4150-935E-9A38DD6D7DFB

P304

Q33959672-BFBBC320-CCE4-465F-BA67-78E786A92EC3

P31

Q33959672-DF865662-1A60-493A-A48D-C2820853558C

P356

Q33959672-AC4AB440-7211-4402-819A-E2B07604D094

P407

Q33959672-A8884AD1-796B-476E-9394-E9A2793305E6

P433

Q33959672-D403FA48-B275-4FB3-8C38-57EEA83B37C2

P478

Q33959672-42B57AA1-F389-4B22-8FD0-301ED212223C

P50

Q33959672-1A2A26E4-CFE7-4C7C-991F-B5F624DC2460

Q33959672-D8351186-CBED-4085-AFE5-EA0EEF019B5A

P577

Q33959672-16900DDA-E6E5-4E4E-B7A1-B032ACA28FEA

P698

Q33959672-55A12110-CB70-4AFF-BDE7-CC37130D54F3

P921

Q33959672-7013771C-4399-4260-903C-2463E48D4EB8

P356

P1433

The New England Journal of Medicine

P1476

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

@en

P2093

Alice M Stek

http://www.w3.org/2001/XMLSchema#string

David E Shapiro

http://www.w3.org/2001/XMLSchema#string

Diane Wara

http://www.w3.org/2001/XMLSchema#string

Gwendolyn Scott

http://www.w3.org/2001/XMLSchema#string

M J O'Sullivan

http://www.w3.org/2001/XMLSchema#string

Mary Culnane

http://www.w3.org/2001/XMLSchema#string

Michael D Hughes

http://www.w3.org/2001/XMLSchema#string

Ruth E Tuomala

http://www.w3.org/2001/XMLSchema#string

Yvonne Bryson

http://www.w3.org/2001/XMLSchema#string

P304

1863-1870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA991159

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

346

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12063370

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug